Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT06169631 Recruiting - Anxiety Disorders Clinical Trials

The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology

Start date: April 29, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to test the effects of brief, low-intensity transcranial focused ultrasound (TUS) on electrophysiological, behavioral, and cognitive markers related to anxiety disorders.

NCT ID: NCT06168981 Enrolling by invitation - Anxiety Clinical Trials

The Effect of Preoperative Chewing Gum on Anxiety and Sore Throat in Patients With Laryngeal Mask Airway

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This study was planned to investigate the effect of chewing gum in the preoperative period on patients' sore throat and anxiety levels.

NCT ID: NCT06168253 Recruiting - Social Anxiety Clinical Trials

Text Message Safety Behavior Fading for Social Anxiety

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The current study aims to explore the efficacy of a text message based Safety Behavior Fading Intervention compared to an active control intervention.

NCT ID: NCT06167590 Recruiting - Healthy Clinical Trials

Integrins and Protocadherins in Glutamatergic Circuits: Identification of Common Signaling Pathways and Molecular Targets in Anxiety and Major Depressive Disorders (GAPsy)

GAPsy
Start date: July 15, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to identify biologically viable targets for the treatment of major depressive disorder (MDD) and anxiety disorder (AD) with the ultimate goal of guiding physicians' therapeutic strategies and identifying more effective and safer treatments for patients. Following the inclusion and exclusion criteria, the investigators will recruit 10 patients with a diagnosis of anxious-depressive disorder (MDD-AD) and 10 healthy controls (HC) subjects. Each participant will be evaluated by a team of expert psychologists and physicians, who will be conducting a structured interview and administering a set of psychopathological scales to assess the symptoms' severity. The participants will also undergo7T multimodal neuroimaging session (including T1-weighted, 1H-MRS and fMRI). In the second part of the study, murine models will be used to study the role of integrin β3 (Itgb3) and protocadherin 9 (Pcdh9) in glutamatergic transmission at a molecular level and to evaluate whether the electrophysiological and behavioral defects identified in Itgb3- and Pcdh9-knockout mice can be restored by CRISPR-mediated transcription activation (CRISPRa).

NCT ID: NCT06165861 Completed - Virtual Reality Clinical Trials

The Effect of Using Virtual Reality Glasses on Surgical Fear and Anxiety

Start date: February 14, 2022
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to evaluate the effect of using virtual reality glasses on the surgical fear and anxiety levels of patients undergoing open heart surgery on the morning of surgery. The main hypotheses are: 1. The surgical fear level of patients who use virtual reality glasses on the morning of surgery is lower than patients who do not use virtual reality glasses. 2. The anxiety level of patients who use virtual reality glasses on the morning of surgery is lower than patients who do not use virtual reality glasses. Before the surgery, study group patients will be asked to watch videos using virtual reality glasses.

NCT ID: NCT06163599 Not yet recruiting - Anxiety Disorders Clinical Trials

Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The primary aim of our study is to determine the effectiveness of an transdiagnostic telenovela video intervention in reducing anxiety and depressive symptoms using a pre/post-test design with Spanish-speaking Latinxs.

NCT ID: NCT06162624 Not yet recruiting - Depression Clinical Trials

Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons

Start date: September 2024
Phase: N/A
Study type: Interventional

The goal of this research study is to adapt an ACT-self-help workbook to the prison setting and determine the feasibility acceptability, and effectiveness of this workbook. Participants can expect to be in the study for 13 weeks.

NCT ID: NCT06156306 Recruiting - Anxiety Clinical Trials

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.

NCT ID: NCT06155838 Enrolling by invitation - Depression Clinical Trials

Reducing Depression and Anxiety Among Teens

Start date: November 27, 2023
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to assess the efficacy of the Early Adolescent Skills for Emotions (EASE) program, a school-based, non-specialist psychosocial intervention developed by the WHO for LMICs, in alleviating Anxiety and Depression among teens aged 13-19. The primary inquiries it seeks to address include: Does the EASE intervention effectively reduce anxiety and depression scores 12 weeks after implementation? - Can the EASE intervention enhance quality of life, improve problem-solving skills, and increase perceived emotional support? - Is the EASE intervention beneficial for enhancing the psychological well-being of parents and fostering positive parent-teen relationships?

NCT ID: NCT06155565 Not yet recruiting - Anxiety Disorder Clinical Trials

Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research

Start date: December 2024
Phase:
Study type: Observational

Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.